EE733 Transfusion-Related Cost and Time Burden in JAKi-Naïve and JAKi-Experienced Patients With Myelofibrosis Treated With Momelotinib and Ruxolitinib From the SIMPLIFY 1 and 2 Studies: A Brazilian Supplementary Health Perspective
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1111
https://www.valueinhealthjournal.com/article/S1098-3015(25)03668-X/fulltext
Title :
EE733 Transfusion-Related Cost and Time Burden in JAKi-Naïve and JAKi-Experienced Patients With Myelofibrosis Treated With Momelotinib and Ruxolitinib From the SIMPLIFY 1 and 2 Studies: A Brazilian Supplementary Health Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03668-X&doi=10.1016/j.jval.2025.09.1111
First page :
Section Title :
Open access? :
No
Section Order :
10652